Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo

Abstract

A novel injectable saRNA-oligonucleotide that enhances C/EBPα expression successfully reduces tumor burden and simultaneously improves liver function in a clinically relevant liver cirrhosis/HCC model.